Morbidity and Mortality Weekly Report (MMWR)

This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households.

This report describes a recommendation for using a 4-month regimen for the treatment of drug-susceptible pulmonary tuberculosis.

This report describes updated guidance on use of the Ebola vaccine.

This report describes age-adjusted suicide rates for males and females in the U.S.

MMWR erratum volume 71, number 3.

This report describes the NFL’s test-to-release COVID-19 mitigation strategy.

This report describes changes in U.S. suicide rates from 2019 to 2020.

This report describes the percentage of positive antigen test results following COVID-19 isolation.

This report describes increases in emergency department visits for mental health conditions among adolescent females in 2020, 2021, and 2022.

This report describes how overall pediatric emergency department visits decreased in 2020, 2021, and January 2022 compared with 2019 but COVID-19 visits predominated.

This report describes changes in the 2022 child and adolescent immunization schedule.

This report describes an outbreak of the SARS-CoV-2 Omicron variant among people attending a convention in New York City.

This report describes SARS-CoV-2 transmission at a large indoor convention among a highly vaccinated population.

CDC reports on assisted reproductive technology procedures performed in 2018.

This report describes an outbreak of Delta variant aboard a U.S. Navy ship.

This report describes death rates attributed to excessive cold or hypothermia.

This report describes increases in COVID-19 hospitalization rates among children and adolescents during Omicron, especially among children not yet eligible for vaccination.

This report describes maternal mRNA vaccine effectiveness against COVID-19 hospitalizations among infants under 6 months of age.

This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.

This report describes how vaccine effectiveness against COVID-19–associated emergency department/urgent care visits and hospitalizations was higher after the third dose but decreased with time.

This report describes dental care rates among children with and without heart conditions.

This report describes antibiotic prescribing rates in a peer comparison.

This report describes genomic surveillance sequencing of COVID-19 variants by jurisdiction.

This report describes tiredness among children and adolescents by age and screentime.

This report describes global progress towards rubella elimination.

This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.

This report describes face mask or respirator effectiveness in helping protect against COVID-19 infection.

This report describes rates of emergency department visits related to mental health disorders.

This report describes self-reported physical health among adults in both rural and urban areas of the United States.

MMWR erratum volume 70, number 51–52.

This report describes COVID-19 vaccination coverage among adults diagnosed with HIV infection.

This report describes COVID-19 vaccination coverage by sexual orientation and gender identity.

This report describes social vulnerability and rates of HIV diagnoses among black adults.

This report describes COVID-19 incidence and hospitalization rates during Omicron predominance in January 2022.

This report describes the percentage of adults with diabetes by disability status and age group.

MMWR erratum volume 71, number 2.

MMWR erratum volume 71, number 1.

This report describes an increasing presence of para-fluorofentanyl in emergency department patients in Knox County, Tennessee..

This report describes the Advisory Committee on Immunization Practice recommendations for administering the pneumococcal conjugate vaccine to U.S. adults.

This report describes the effectiveness of the third dose of Pfizer-BioNTech and Moderna vaccines in preventing hospitalizations.

This report provides a detailed summary of data from NVDRS on violent deaths that occurred in 2018.

This report describes disease severity and healthcare utilization during the emergence of the Omicron variant of the virus that causes COVID-19 in the U.S.

This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.

This report describes COVID-19 cases and hospitalizations by vaccination status and previous COVID-19 diagnosis before and after the Delta variant became predominant.

This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.

This report summarizes health data reported to the Electronic Disease Notification system for refugees, immigrants, and eligible others who arrived in the United States during 2014–2019.

This report describes the percentage of children with more than two hours of screen time per weekday.

This report describes early evidence of the Omicron variant in community wastewater.

This report describes updated recommendations from the ACIP to the use of Janssen mRNA COVID-19 vaccines.

This report describes a decrease in wild poliovirus type 1 during 2021 among children in Afghanistan.